CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Gift Director gave 4,000 shares (gift)
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 40,000 shares at an average $15.11 ($604,556)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $15.88 ($79,412)
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 53,926 shares at an average $17.05 ($919,589)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale Director sold 41,174 shares at an average $17.01 ($700,355)
- 4 Open-market sale Director sold 52,037 shares at an average $16.57 ($862,109)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $15.98 ($79,908)
- 4 Open-market sale Director sold 7,324 shares at $16.16 ($118,349)
- 4 Open-market sale Director sold 45,539 shares at an average $16.45 ($749,002)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 15 of 44 · 872 filings